| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash provided by financing activities | 8,558,488 | 8,317,283 |
| Net decrease in cash and cash equivalents | -15,490,939 | -9,816,096 |
| Cash and cash equivalents at beginning of period | 41,689,591 | - |
| Cash and cash equivalents at end of period | 26,198,652 | - |
PDS Biotechnology Corp (PDSB)
PDS Biotechnology Corp (PDSB)